Stem Cell Therapy for Neurological Disorders
Stem cell therapy for neurological disorders is an emerging field that aims to repair or replace damaged neurons and restore lost neurological function. Various stem cell types, including neural stem cells, mesenchymal stem cells, and induced pluripotent stem cells (iPSCs), are being investigated for therapeutic applications. These therapies have shown potential in treating conditions such as Parkinson's disease, Alzheimer's disease, stroke, spinal cord injury, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). Stem cells may promote tissue repair through neuronal replacement, neuroprotection, immunomodulation, and the secretion of regenerative growth factors. Advances in biomaterials, gene editing, and targeted cell delivery are improving the safety and effectiveness of stem cell-based interventions. Ongoing preclinical and clinical studies continue to evaluate their long-term efficacy, functional recovery, and safety profiles. Researchers are also addressing challenges related to cell survival, immune rejection, tumorigenicity, and standardized manufacturing processes. Overall, stem cell therapy offers promising opportunities for developing innovative treatments for neurological disorders and improving patients' quality of life.
Related Conference of Stem Cell Therapy for Neurological Disorders
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
19th International Conference on Human Genomics and Genomic Medicine
Stem Cell Therapy for Neurological Disorders Conference Speakers
Recommended Sessions
- Adult Stem Cells and Tissue-Specific Regeneration
- Cardiovascular Regeneration and Stem Cell Therapeutics
- Embryonic Stem Cells and Pluripotent Stem Cells
- Hematopoietic Stem Cell Transplantation
- Induced Pluripotent Stem Cells (iPSCs)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications
- Orthopedic Regenerative Medicine and Bone Tissue Engineering
- Regenerative Medicine: Current Advances and Future Perspectives
- Stem Cell Biology and Cellular Mechanisms
- Stem Cell Therapy for Neurological Disorders
Related Journals
Are you interested in
- Adult Stem Cells and Tissue-Specific Regeneration - Regenerative Medicine_2026 (France)
- Advanced Gene Therapeutics - Cell Signaling 2026 (France)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioengineering Therapeutics - Cell Signaling 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Cardiovascular Regeneration and Stem Cell Therapeutics - Regenerative Medicine_2026 (France)
- Cell Biology - Cell Signaling 2026 (France)
- Cell Culture and Bioprocessing - Cell Signaling 2026 (France)
- Cell Cycle/Proliferation - Cell Signaling 2026 (France)
- Cell Death and Viability - Cell Signaling 2026 (France)
- Cell Science and Stem Cell Research - Cell Signaling 2026 (France)
- Cellular Signaling - Cell Signaling 2026 (France)
- Cellular Therapies - Cell Signaling 2026 (France)
- Clinical Trials and Research in Stem Cell in Cancer Therapy - Cell Signaling 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Embryonic Stem Cells and Pluripotent Stem Cells - Regenerative Medicine_2026 (France)
- Epidermis Stem Cell & Cancer Epidemiology - Cell Signaling 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Hematopoietic Stem Cell Transplantation - Regenerative Medicine_2026 (France)
- Human Gene Therapy - Cell Signaling 2026 (France)
- Immunotherapy - Cell Signaling 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) - Regenerative Medicine_2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells: Biology and Therapeutic Applications - Regenerative Medicine_2026 (France)
- Molecular Epigenetics - Cell Signaling 2026 (France)
- Nano-Therapy - Cell Signaling 2026 (France)
- Nanotechnology in Stem Cell - Cell Signaling 2026 (France)
- Orthopedic Regenerative Medicine and Bone Tissue Engineering - Regenerative Medicine_2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine - Cell Signaling 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Regenerative Medicine: Current Advances and Future Perspectives - Regenerative Medicine_2026 (France)
- Regulatory and Ethical Issues of Therapies. - Cell Signaling 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Regenerative Medicine_2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell in Drug Development - Cell Signaling 2026 (France)
- Stem Cell Therapies - Cell Signaling 2026 (France)
- Stem Cell Therapy for Neurological Disorders - Regenerative Medicine_2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
